If you were spending upwards of $2.6 billion and 12 years on a product that would ultimately fail, wouldn’t you rather know sooner than later? Cut your losses after year 3 and refocus your resources on the next promising idea?
That’s the position in which pharmaceutical companies find themselves. In fact, it’s their business model. The resources needed to take a drug treatment from concept to reality are extraordinary. And if a treatment is not going to work, the researchers need to know. Now.
To learn more about meeting the promises of cryo-EM, download our free white paper. You’ll gain insights on:
A typical cryo-EM workflow and the potential for backlogs
Utilization conflict and how to minimize investment
How Cray’s expertise can net a 60% speed advantage
With our 45 years of experience handling data-centric workflows, Cray’s solutions are pre-configured to speed time to innovation, handle today’s workloads, and scale to meet the data demands of tomorrow.
To get your free white paper, simply fill out the form.
Explore related resources: